Systematic Review and Meta-Analysis of Multitargeted Tyrosine Kinase Inhibitors in Patients With Intractable Metastatic Colorectal Cancer

Systematic Review and Meta-Analysis of Multitargeted Tyrosine Kinase Inhibitors in Patients With Intractable Metastatic Colorectal Cancer

Background: The treatment options for intractable metastatic colorectal cancer include regorafenib, trifluridine/tipiracil, and fruquintinib. In this study, we aimed to conduct a network meta-analysis for comparing the efficacy of these agents. Methods: We searched the PubMed, EMBASE, Cochrane Centr...

Full description

Bibliographic Details
Main Authors:	Zhenzhen Gao PhD, Chenxi Cao MD, Yi Bao PhD, Yaohua Fan MD, Gang Chen MD, Peng Fu MD
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-09-01
Series:	Technology in Cancer Research & Treatment
Online Access:	https://doi.org/10.1177/1533033820943241

Similar Items

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors
by: Haoran Zhang MD, et al.
Published: (2020-11-01)

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
by: Miguel Carracedo, PhD, et al.
Published: (2020-03-01)

High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib
by: Atsushi Osoegawa, MD, PhD, et al.
Published: (2021-07-01)

Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report
by: Diego Enrico, MD, et al.
Published: (2020-06-01)

Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in EGFR–Mutated Lung Cancer
by: Naoki Haratake, MD, PhD, et al.
Published: (2020-11-01)

Anterior cingulotomy for intractable pain
by: Nitin Agarwal, MD, et al.
Published: (2016-12-01)

A Case of Traumatic Intractable Leg Ulcer with Lymphorrhea Diagnosed Using ICG Lymphography
by: Atsuyoshi Osada, MD, PhD, et al.
Published: (2021-03-01)

Increase in Blood Pressure Associated With Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor
by: Sarah Waliany, MD, MS, et al.
Published: (2019-09-01)

Closure of Intractable Enterocutaneous Fistula with a Rectus Abdominis Musculocutaneous Flap
by: Shin-ichiro Hashiguchi, MD, et al.
Published: (2019-06-01)

EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors
by: Pedro E.N.S. Vasconcelos, MS, et al.
Published: (2020-09-01)

Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis
by: Masato Sawamura, MD, PhD, et al.
Published: (2020-12-01)

EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma
by: Chan Xiang, PhD, et al.
Published: (2021-07-01)

Single-Isocenter Multitarget Stereotactic Radiosurgery Is Safe and Effective in the Treatment of Multiple Brain Metastases
by: Joshua D. Palmer, MD, et al.
Published: (2020-01-01)

Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors
by: Keunchil Park, MD, PhD, et al.
Published: (2021-09-01)

Multiple myeloma with intractable lumbar pain and diagnostic challenge with MRI: A case report
by: Min Jae Myung, MD, et al.
Published: (2021-03-01)

A case of Merkel cell carcinoma development under treatment with a Janus kinase inhibitor
by: Yuta Koike, MD, PhD, et al.
Published: (2017-11-01)

Differential Inhibitory Actions of Multitargeted Tyrosine Kinase Inhibitors on Different Ionic Current Types in Cardiomyocytes
by: Wei-Ting Chang, et al.
Published: (2020-02-01)

An unusual approach to intractable AVNRT in a pediatric patient
by: Maria Cecilia Gonzalez, MD, et al.
Published: (2015-01-01)

Acquired Resistance Mechanism for MET Tyrosine Kinase Inhibitor
by: Toshio Fujino, MD, et al.
Published: (2021-03-01)

Intractable pyoderma gangrenosum in a Crohn's disease patient on vedolizumab
by: Jennifer E. Yeh, PhD, et al.
Published: (2017-03-01)

Tyrosine Kinase Inhibitors in Pulmonary Vascular Disease
by: John J. Ryan, MD
Published: (2016-12-01)

Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer
by: Jiaqi Han MD, et al.
Published: (2020-02-01)

Retrospective Real-World Outcomes for Patients With ALK-Rearranged Lung Cancer Receiving ALK Receptor Tyrosine Kinase Inhibitors
by: Amanda J.W. Gibson, BSc (Hons), et al.
Published: (2021-04-01)

Small Molecule Tyrosine Kinase Inhibitor Nintedanib Reduces Development of Cardiac Allograft Vasculopathy in Murine Aortic Allografts
by: Annika Gocht, et al.
Published: (2018-07-01)

Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
by: Rana Kanaan, et al.
Published: (2017-10-01)

Tyrosine Kinase Inhibitors’ Newly Reported Endocrine Side Effect: Pazopanib-Induced Primary Adrenal Insufficiency in a Patient With Metastatic Renal Cell Cancer
by: Ghada Elshimy MD, et al.
Published: (2020-06-01)

Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome
by: Kate R. Secombe BHSc (Hons), et al.
Published: (2020-06-01)

Outcomes in Patients With 4 to 10 Brain Metastases Treated With Dose-Adapted Single-Isocenter Multitarget Stereotactic Radiosurgery: A Prospective Study
by: Grace J. Kim, MD, PhD, et al.
Published: (2021-11-01)

Use of etanercept in management of tyrosine kinase-inhibitor-induced erythema nodosum
by: Erisa Alia, MD, et al.
Published: (2020-06-01)

First Application of Ketogenic Diet on a Child With Intractable Epilepsy in Ghana
by: Dezhi Cao MD, et al.
Published: (2015-09-01)

Total pancreatectomy with islet autotransplantation in diabetic and pre-diabetic patients with intractable chronic pancreatitis
by: Piotr J. Bachul, MD, et al.
Published: (2020-06-01)

Pulmonary lymphatic involvement in metastatic uterine sarcomas: imaging and pathological appearance
by: Takahiro Kitayama, MD, et al.
Published: (2021-09-01)

Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study
by: Chia-Ling Li MD, et al.
Published: (2019-02-01)

Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials
by: Kim S, et al.
Published: (2014-05-01)

New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors: from molecular target to clinical trials
by: Kai eQu, et al.
Published: (2016-01-01)

Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro
by: Johanna Weiss, et al.
Published: (2014-12-01)

Atypical case of telangiectatic metastatic breast carcinoma presenting as purpura
by: Ken Shiraishi, MD, PhD, et al.
Published: (2017-07-01)

Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer
by: Shan Xu PhD, et al.
Published: (2021-09-01)

Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma
by: Elena V. Poddubskaya, et al.
Published: (2018-09-01)

The Long Half-Life of Programmed Cell Death Protein 1 Inhibitors May Increase the Frequency of Immune-Related Adverse Events After Subsequent EGFR Tyrosine Kinase Inhibitor Therapy
by: Yuki Shinno, MD, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_4bc0mdlfnepl6rkrcuiata9834